Huang K et al. |
Novel role for NFAT3 in ERK-mediated regulation of CXCR4. |
2014 |
PLoS ONE |
pmid:25514788
|
Saito K et al. |
Severe diffuse duodenitis successfully treated with intravenous tacrolimus after colectomy for ulcerative colitis. |
2014 |
Intern. Med. |
pmid:25366006
|
Labrador J et al. |
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. |
2014 |
Bone Marrow Transplant. |
pmid:24566710
|
Liu Y et al. |
Role of retrograde trafficking in stress response, host cell interactions, and virulence of Candida albicans. |
2014 |
Eukaryotic Cell |
pmid:24363364
|
Singh K et al. |
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. |
2014 |
Am. J. Transplant. |
pmid:25359003
|
Wei TQ et al. |
Sandwich assay for tacrolimus using 2 antitacrolimus antibodies. |
2014 |
Clin. Chem. |
pmid:24381229
|
Hamzah S et al. |
Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients. |
2014 |
Can. J. Physiol. Pharmacol. |
pmid:24383873
|
Amorim J et al. |
Tacrolimus-induced neutropenia in a cardiac transplant patient. |
2014 |
Pediatr Transplant |
pmid:24384051
|
Silva HT et al. |
Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. |
2014 |
Transplantation |
pmid:24521771
|
Kiiski V et al. |
Long-term safety of topical pimecrolimus and topical tacrolimus in atopic blepharoconjunctivitis. |
2014 |
JAMA Dermatol |
pmid:24500107
|
Kurzawski M et al. |
CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients. |
2014 |
Pharmacogenomics |
pmid:24444408
|
Xue F et al. |
CYP3A5 genotypes affect tacrolimus pharmacokinetics and infectious complications in Chinese pediatric liver transplant patients. |
2014 |
Pediatr Transplant |
pmid:24438215
|
Lapeyraque AL et al. |
Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study. |
2014 |
Pediatr. Nephrol. |
pmid:24435759
|
Højfeldt JW et al. |
Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor. |
2014 |
Mol. Endocrinol. |
pmid:24422633
|
Chen YK et al. |
Personalized tacrolimus dose requirement by CYP3A5 but not ABCB1 or ACE genotyping in both recipient and donor after pediatric liver transplantation. |
2014 |
PLoS ONE |
pmid:25310192
|
Saso S et al. |
Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a long-term viability study. |
2014 |
Eur. J. Obstet. Gynecol. Reprod. Biol. |
pmid:25306223
|
Mekaj AY et al. |
Application of topical pharmacological agents at the site of peripheral nerve injury and methods used for evaluating the success of the regenerative process. |
2014 |
J Orthop Surg Res |
pmid:25303779
|
Satoh S et al. |
Pharmacokinetic and CYP3A5 pharmacogenetic differences between once- and twice-daily tacrolimus from the first dosing day to 1 year after renal transplantation. |
2014 |
Pharmacogenomics |
pmid:25303300
|
Steinebrunner N et al. |
Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study. |
2014 |
Ann. Transplant. |
pmid:24457606
|
Müller GG et al. |
Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study. |
2014 |
Eye Contact Lens |
pmid:24418865
|
Meyer KC et al. |
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. |
2014 |
Eur. Respir. J. |
pmid:25359357
|
Hesselink DA et al. |
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. |
2014 |
Clin Pharmacokinet |
pmid:24249597
|
Ahmed S et al. |
Photocleavable dimerizer for the rapid reversal of molecular trap antagonists. |
2014 |
J. Biol. Chem. |
pmid:24421317
|
Souto-RodrÃguez R et al. |
Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol. |
2014 |
Transplant. Proc. |
pmid:25420839
|
Al-Amri AM |
Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. |
2014 |
Am. J. Ophthalmol. |
pmid:24439439
|
de la Fuente S et al. |
Long-term survivors after pediatric liver transplatation are at increased risk for development of cardiovascular disease events: analysis of 30 cases. |
2014 |
Transplant. Proc. |
pmid:25420837
|
Kim JR et al. |
20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC/Nga mice. |
2014 |
J Ethnopharmacol |
pmid:24269244
|
Tavira B et al. |
Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients. |
2014 |
Gene |
pmid:24445060
|
Lin Y et al. |
PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. |
2014 |
Am. J. Pathol. |
pmid:24269558
|
Barreiro C and MartÃnez-Castro M |
Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). |
2014 |
Appl. Microbiol. Biotechnol. |
pmid:24272367
|
Zhu X et al. |
Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults. |
2014 |
Blood Cells Mol. Dis. |
pmid:24931461
|
Salehi-Najafabadi Z et al. |
The gamma-butyrolactone receptors BulR1 and BulR2 of Streptomyces tsukubaensis: tacrolimus (FK506) and butyrolactone synthetases production control. |
2014 |
Appl. Microbiol. Biotechnol. |
pmid:24562179
|
Xue W et al. |
Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis. |
2014 |
Chin. Med. J. |
pmid:24931259
|
Gomez-Moyano E et al. |
Periorbital granuloma annulare successfully treated with tacrolimus 0.1% ointment. |
2014 |
Int. J. Dermatol. |
pmid:23432464
|
Doligalski CT et al. |
Sublingual administration of tacrolimus: current trends and available evidence. |
2014 |
Pharmacotherapy |
pmid:25251980
|
Koren G and Rieder M |
Measuring oral bioavailability of tacrolimus. |
2014 |
Pediatr Transplant |
pmid:25250966
|
Souza MC et al. |
Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity. |
2014 |
Curr. Eye Res. |
pmid:24325382
|
Talreja N et al. |
Successful desensitization to agalsidase beta after anaphylaxis. |
2014 |
Ann. Allergy Asthma Immunol. |
pmid:24331397
|
Chen Z et al. |
Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p. |
2014 |
Biochim. Biophys. Acta |
pmid:24333836
|
Ueda K et al. |
Early corticosteroid withdrawal in the real world: a long-term analysis of kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry. |
2014 |
Ann. Transplant. |
pmid:24535029
|
Musuamba FT et al. |
Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation. |
2014 |
Ther Drug Monit |
pmid:24081207
|
Nasu R et al. |
Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. |
2014 |
Ann. Hematol. |
pmid:24590535
|
Ricciardelli I et al. |
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells. |
2014 |
Blood |
pmid:25185261
|
Mujtaba MA et al. |
Conversion from tacrolimus to belatacept to prevent the progression of chronic kidney disease in pancreas transplantation: case report of two patients. |
2014 |
Am. J. Transplant. |
pmid:25179306
|
Rahman Z et al. |
Determination of tacrolimus crystalline fraction in the commercial immediate release amorphous solid dispersion products by a standardized X-ray powder diffraction method with chemometrics. |
2014 |
Int J Pharm |
pmid:25173870
|
Takeuchi T et al. |
Tacrolimus-induced left ventricular apical hypertrophy in a patient with post-allogeneic hematopoietic stem cell transplantation. |
2014 |
Int. J. Cardiol. |
pmid:25131917
|
Huang H et al. |
Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells. |
2014 |
Chin. Med. J. |
pmid:25131236
|
Choi SW et al. |
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial. |
2014 |
Lancet Oncol. |
pmid:24295572
|
Görzer I et al. |
Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation. |
2014 |
J. Heart Lung Transplant. |
pmid:24559947
|
Barnieh L et al. |
The cost of kidney transplant over time. |
2014 |
Prog Transplant |
pmid:25193726
|
Guy S et al. |
Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report. |
2014 |
Transplant. Proc. |
pmid:25179161
|
Yuan C et al. |
A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood. |
2014 |
Bioanalysis |
pmid:25077621
|
Aulagnon F et al. |
Diarrhea after kidney transplantation: a new look at a frequent symptom. |
2014 |
Transplantation |
pmid:25073040
|
Beermann KJ et al. |
Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. |
2014 |
Clin Transplant |
pmid:24754564
|
Zwiech R |
[The early C4d urinary excretion and long-term kidney graft survival in patients treated with tacrolimus and mycophenolate mophetil]. |
2014 |
Pol. Merkur. Lekarski |
pmid:24779215
|
Matia I et al. |
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. |
2014 |
Ann. Transplant. |
pmid:24815872
|
Harada N et al. |
[Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment]. |
2014 |
Nippon Ganka Gakkai Zasshi |
pmid:24864437
|
Denfield SW |
Oxidative and other stresses following pediatric heart transplantation. |
2014 |
Pediatr Transplant |
pmid:25250969
|
Izumi Y et al. |
Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients. |
2014 |
Tohoku J. Exp. Med. |
pmid:25175032
|
Boschetti G et al. |
Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment. |
2014 |
Dig Liver Dis |
pmid:25023007
|
Piao SG et al. |
Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. |
2014 |
Transplantation |
pmid:24825522
|
Personett HA et al. |
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. |
2014 |
Transplant. Proc. |
pmid:25017243
|
Anderson JS et al. |
Statistical allosteric coupling to the active site indole ring flip equilibria in the FK506-binding domain. |
2014 |
Biophys. Chem. |
pmid:25016286
|
Navas-López VM et al. |
Oral tacrolimus for pediatric steroid-resistant ulcerative colitis. |
2014 |
J Crohns Colitis |
pmid:23582736
|
van Gelder T et al. |
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. |
2014 |
Nat Rev Nephrol |
pmid:25247332
|
Tapirdamaz Ö et al. |
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation. |
2014 |
Pharmacogenet. Genomics |
pmid:25014506
|
Helmschrott M et al. |
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. |
2014 |
Drug Des Devel Ther |
pmid:25246772
|
Matsuda Y et al. |
Once-daily oral administration of cyclosporine in a lung transplant patient with a history of renal toxicity of calcineurin inhibitors. |
2014 |
Interact Cardiovasc Thorac Surg |
pmid:24659549
|
Lunde I et al. |
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. |
2014 |
Eur. J. Clin. Pharmacol. |
pmid:24658827
|
Picchianti-Diamanti A et al. |
P-glycoprotein and drug resistance in systemic autoimmune diseases. |
2014 |
Int J Mol Sci |
pmid:24658440
|
Enderby CY et al. |
Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study. |
2014 |
Clin Transplant |
pmid:24931421
|
Webster P et al. |
Tacrolimus is an effective treatment for lupus nephritis in pregnancy. |
2014 |
Lupus |
pmid:24928830
|
Wolfram D et al. |
Insights from computational modeling in inflammation and acute rejection in limb transplantation. |
2014 |
PLoS ONE |
pmid:24926998
|
Zhao X et al. |
[A retrospective cohort study regarding the effect of sirolimus-based immunosuppression protocol on the long-term survival of hepatocellular carcinoma patients after liver transplantation]. |
2014 |
Zhonghua Wai Ke Za Zhi |
pmid:24924566
|
Saito E et al. |
Efficacy of salvage therapy and its effect on operative outcomes in patients with ulcerative colitis. |
2014 |
Digestion |
pmid:24458114
|
Carbajo-Lozoya J et al. |
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. |
2014 |
Virus Res. |
pmid:24566223
|
Feng S et al. |
A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. |
2014 |
Angew. Chem. Int. Ed. Engl. |
pmid:24841150
|
Rotter D et al. |
Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion. |
2014 |
J. Mol. Cell. Cardiol. |
pmid:24838101
|
Ren Y et al. |
Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice. |
2014 |
Int. Immunopharmacol. |
pmid:24836681
|
Li H et al. |
A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC)--combining tacrolimus with FLC. |
2014 |
FEMS Yeast Res. |
pmid:24830342
|
Wang YB et al. |
In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization. |
2014 |
AAPS PharmSciTech |
pmid:24824172
|
Welzl K et al. |
Effect of different immunosuppressive drugs on immune cells from young and old healthy persons. |
2014 |
Gerontology |
pmid:24434865
|
Yang LM et al. |
Experimental research on end-to-side anastomosis of peripheral nerves and effect of FK506 on end-to-side anastomosis. |
2014 |
Bratisl Lek Listy |
pmid:25573729
|
Fazal MA et al. |
Dyslipidaemia among renal transplant recipients: cyclosporine versus tacrolimus. |
2014 |
J Pak Med Assoc |
pmid:25272531
|
Taimur S et al. |
Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant. |
2014 |
Transpl Infect Dis |
pmid:24251680
|
Stewart JI et al. |
Reverse halo sign on chest imaging in a renal transplant recipient. |
2014 |
Transpl Infect Dis |
pmid:24289813
|
Muduma G et al. |
A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability. |
2014 |
J Med Econ |
pmid:24754700
|
Shihab FS et al. |
Tacrolimus exposure in the real world: an analysis from the Mycophenolic acid Observational REnal transplant study. |
2014 |
Clin Transplant |
pmid:24754603
|
Taube D et al. |
Generic tacrolimus in solid organ transplantation. |
2014 |
Clin Transplant |
pmid:24750309
|
Bloch J et al. |
Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients. |
2014 |
Pharmacogenomics |
pmid:25521359
|
Nacif LS et al. |
An analysis of tacrolimus-related complications in the first 30 days after liver transplantation. |
2014 |
Clinics (Sao Paulo) |
pmid:25518032
|
Cvetkovic TP et al. |
Gender differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus-based immunosuppression. |
2014 |
Int Urol Nephrol |
pmid:24101297
|
Hodzic E et al. |
Posterior reversible encephalopathy syndrome (PRES) as a complication of immunosuppressive therapy in renal transplantation in children. |
2014 |
Med Arh |
pmid:25195358
|
Chen Y et al. |
Comparison of long-term impact of immunosuppressants at therapeutic doses on hepatic function and histological changes in unilateral nephrectomized rats. |
2014 |
Exp. Toxicol. Pathol. |
pmid:25081300
|
Nishimoto K et al. |
[Case of organizing pneumonia associated with sweet's syndrome]. |
2014 |
Arerugi |
pmid:25163580
|
Hässig A et al. |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor. |
2014 |
Transpl Infect Dis |
pmid:24134704
|
Elens L et al. |
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks. |
2014 |
Br J Clin Pharmacol |
pmid:24118098
|
Manousou P et al. |
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. |
2014 |
Gut |
pmid:24131637
|
Xie M et al. |
Brucellosis infection in an adult liver transplant recipient. |
2014 |
Transpl Infect Dis |
pmid:24666385
|
Takazono T et al. |
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. |
2014 |
BMC Infect. Dis. |
pmid:24576098
|